Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs Mycophenolate in Autoimmune Hepatitis (TAILOR)
NCT05221411Phase 4Unknown
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2022
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in autoimmune hepatitis (AIH) comparing Tacrolimus with Mycophenolate Mofetil (2 arms). Primary endpoint: Complete biochemical remission at 52 weeks. Status: unknown.
02
Drugs
tacrolimus + Wuzhi capsulemycophenolate mofetil
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NCT05221411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05221411.